Informed Consent
PRESENT STUDY: Assessing Psychologists’ Knowledge and Attitudes Towards the Therapeutic Utility of Psychedelics in the Treatment of Psychiatric Concerns
RESEARCHERS:
Bhupin Butaney, Ph.D., (PI)
Thomas Virden, III, Ph.D.
Madeline Terrill, MA
You are invited to participate in a research study. Participation is completely voluntary. Please review this form thoroughly. If you agree to participate, you reserve the right to opt out at any given time without penalty.
In the unlikely event that you suffer injury or illness directly related to your participation in this research project, upon your request, Midwestern University (MWU) will arrange for the provision of medical treatment. Payment for such treatment will be your responsibility, although your commercial insurance carrier, if any, may cover medical expenses. MWU will not provide any monetary compensation for research-related injury or illness or pay for treatment outside of any MWU-affiliated Hospitals or Medical Centers. You are not waiving your legal rights by volunteering to participate in this study.
PURPOSE OF THIS STUDY:
This study aims to evaluate the knowledge and attitudes toward psychedelics and their application within the psychiatric treatment among psychologists and those training to become psychologists.
SURVEY TOPICS:
This survey includes multiple-choice and Likert scale format questions related to basic demographic information and your knowledge of, attitudes about, and interest in psychedelics and their potential therapeutic utility.
MINIMAL RISKS:
There are minimal risks associated with participation in this study.
Breach of Confidentiality: Online data may be intercepted or hacked by unaffiliated persons. This is a risk you experience any time you provide information online.
We are minimizing this risk in the following ways:
RESEARCHERS:
Bhupin Butaney, Ph.D., (PI)
Thomas Virden, III, Ph.D.
Madeline Terrill, MA
You are invited to participate in a research study. Participation is completely voluntary. Please review this form thoroughly. If you agree to participate, you reserve the right to opt out at any given time without penalty.
In the unlikely event that you suffer injury or illness directly related to your participation in this research project, upon your request, Midwestern University (MWU) will arrange for the provision of medical treatment. Payment for such treatment will be your responsibility, although your commercial insurance carrier, if any, may cover medical expenses. MWU will not provide any monetary compensation for research-related injury or illness or pay for treatment outside of any MWU-affiliated Hospitals or Medical Centers. You are not waiving your legal rights by volunteering to participate in this study.
PURPOSE OF THIS STUDY:
This study aims to evaluate the knowledge and attitudes toward psychedelics and their application within the psychiatric treatment among psychologists and those training to become psychologists.
SURVEY TOPICS:
This survey includes multiple-choice and Likert scale format questions related to basic demographic information and your knowledge of, attitudes about, and interest in psychedelics and their potential therapeutic utility.
MINIMAL RISKS:
There are minimal risks associated with participation in this study.
Breach of Confidentiality: Online data may be intercepted or hacked by unaffiliated persons. This is a risk you experience any time you provide information online.
We are minimizing this risk in the following ways:
- Data is anonymous. No identifying information is collected.
- Data will be collected and safeguarded within the secure, password-protected Survey Monkey system (Survey Monkey Privacy Notice) and a password-secured storage device.
BENEFITS:
Participants may experience potential benefits knowing they have contributed to an increased awareness and knowledge base for psychedelic medicine. On a larger scale, we hope that the information obtained from this study may benefit the general public by contributing to advances in psychiatric treatment.
TIME COMMITMENT: The survey will take approximately 10 minutes.
COMPENSATION: There will be no compensation for participation.
CONFIDENTIALITY AND DATA SECURITY:
Where will data be stored? All data will be stored on the Survey Monkey servers or downloaded to a password-secured storage device.
How long will it be kept? Electronic data will be kept until the completion of the study and dissertation project.
Who can see my data? We (the researchers) will have access to de-identified data. Findings may be shared in publications or conference presentations. If so, the results will be aggregated (grouped) data with no individual results.
Participants may experience potential benefits knowing they have contributed to an increased awareness and knowledge base for psychedelic medicine. On a larger scale, we hope that the information obtained from this study may benefit the general public by contributing to advances in psychiatric treatment.
TIME COMMITMENT: The survey will take approximately 10 minutes.
COMPENSATION: There will be no compensation for participation.
CONFIDENTIALITY AND DATA SECURITY:
Where will data be stored? All data will be stored on the Survey Monkey servers or downloaded to a password-secured storage device.
How long will it be kept? Electronic data will be kept until the completion of the study and dissertation project.
Who can see my data? We (the researchers) will have access to de-identified data. Findings may be shared in publications or conference presentations. If so, the results will be aggregated (grouped) data with no individual results.
VOLUNTARY PARTICIPATION:
You do not have to agree to be in this study and may change your mind anytime.
This study has been reviewed and approved by the MWU Institutional Review Board. If you have questions about this research project or your rights as a research subject, please contact principal investigator, Dr. Bhupin Butaney, at (623) 572-3790 or bbutan@midwestern.edu or MWU's Assistant Vice President of Research, Dr. James Woods, at (630) 515-6173.
Protocol #: IRBAZ-5314
Approval Date: 20-May-2024
You do not have to agree to be in this study and may change your mind anytime.
This study has been reviewed and approved by the MWU Institutional Review Board. If you have questions about this research project or your rights as a research subject, please contact principal investigator, Dr. Bhupin Butaney, at (623) 572-3790 or bbutan@midwestern.edu or MWU's Assistant Vice President of Research, Dr. James Woods, at (630) 515-6173.
Protocol #: IRBAZ-5314
Approval Date: 20-May-2024